Catalyst Wire Dossier Catalyst Wire Dossier

CINQAIR

Reslizumab · Teva Respiratory, LLC
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CINQAIR, covering 2016-03-23 to 2019-01-09. Get the full timeline:

Most recent: FDA Approved: CINQAIR — Supplemental Application (Teva Respiratory, LLC)

See pricing